These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30599218)

  • 21. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
    Hamurtekin E; Bagdas D; Gurun MS
    Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.
    Qi JA; Mosberg HI; Porreca F
    Life Sci; 1990; 47(11):PL43-7. PubMed ID: 2170791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of spinal mu1-opioid receptors to morphine-induced antinociception.
    Sato T; Sakurada S; Takahashi N; Sakurada T; Tan-No K; Wako K; Kisara K
    Eur J Pharmacol; 1999 Mar; 369(2):183-7. PubMed ID: 10206177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
    Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
    Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor-selective antagonism of opioid antinociception in female versus male rats.
    Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
    Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unexpected antinociceptive potency of cyclic [D-Tca1]CTAP: potential for a novel mechanism of action.
    Horan PJ; Wild KD; Kazmierski WM; Ferguson R; Hruby VJ; Weber SJ; Davis TP; Fang L; Knapp RJ; Yamamura HI
    Eur J Pharmacol; 1993 Mar; 233(1):53-62. PubMed ID: 8386089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peripheral antinociceptive effects of the cyclic endomorphin-1 analog c[YpwFG] in a mouse visceral pain model.
    Bedini A; Baiula M; Gentilucci L; Tolomelli A; De Marco R; Spampinato S
    Peptides; 2010 Nov; 31(11):2135-40. PubMed ID: 20713109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antinociceptive Effect of Ghrelin in a Rat Model of Irritable Bowel Syndrome Involves TRPV1/Opioid Systems.
    Mao Y; Li Z; Chen K; Yu H; Zhang S; Jiang M; Ma Y; Liang C; Liu H; Li H; Hua Q; Zhou H; Sun Y; Fan X
    Cell Physiol Biochem; 2017; 43(2):518-530. PubMed ID: 28930716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
    Gergen KA; Zadina JE; Paul D
    Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antinociception after intracerebroventricular administration of naltrindole in the mouse.
    Stapelfeld A; Hammond DL; Rafferty MF
    Eur J Pharmacol; 1992 Apr; 214(2-3):273-6. PubMed ID: 1325358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Supraspinal and spinal cord opioid receptors are responsible for antinociception following intrathecal morphine injections.
    Goodchild CS; Nadeson R; Cohen E
    Eur J Anaesthesiol; 2004 Mar; 21(3):179-85. PubMed ID: 15055889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antinociceptive effects of central administration of the endogenous cannabinoid receptor type 1 agonist VDPVNFKLLSH-OH [(m)VD-hemopressin(α)], an N-terminally extended hemopressin peptide.
    Han ZL; Fang Q; Wang ZL; Li XH; Li N; Chang XM; Pan JX; Tang HZ; Wang R
    J Pharmacol Exp Ther; 2014 Feb; 348(2):316-23. PubMed ID: 24307201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
    Xu JY; Fujimoto JM; Tseng LF
    J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antinociceptive effect of amisulpride in mice is mediated through opioid mechanisms.
    Weizman T; Pick CG; Backer MM; Rigai T; Bloch M; Schreiber S
    Eur J Pharmacol; 2003 Oct; 478(2-3):155-9. PubMed ID: 14575800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Supraspinal antinociception produced by [D-Met2]-FMRFamide in mice.
    Raffa RB; Connelly CD
    Neuropeptides; 1992 Jul; 22(3):195-203. PubMed ID: 1331846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K; Onodera K; Kamei J
    Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.